Member Info for Dr_Horrible

https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-022-03558-5

By-Health currently expects to be in a position to complete the last of its eight studies and file its regulatory submission to the SAMR for Fruitflow in the first half of 2022. If By-Health is successful in obtaining a new permitted health function claim it is currently expected that this would result in some significant orders for Fruitflow, potentially at a multiple of current total sales values.
-———————-
Hopefully submitted within the next 3 months.

If the doctor/consultant was not aware of it, maybe he is not good at his job. You should probably get a second opinion. When getting the Covid jab I was asked if I was on blood thinning medication, I said no, but I am taking Fruitflow. They knew what it was and said that’s fine.

Interesting how the translation comes out as Tomato Water Extract, same as the little Nestle bottles.

I too have been with PXS for 13 or 14 years. However, I have always believed in the product itself, so stuck with it for all these years.

By-Health are the biggest domestic supplier of VDS in China. Their sales are growing massively each year. They lead the sales charts on the main platforms, beating their competition. They have processed many claims through SAMR. Also, they are working with SAMR on standards for the industry. They have invested large sums of money in FF, working with SAMR to carry out 8 studies. I feel they know what they are doing.

If you believe that Provexis will never sell much Fruitflow and never make profit, then you also have to believe that By-Health are crazy and don't know what they are doing either. To me that does not seem to be the case. They are a very switched on and smart company that is doing extremely well and they are telling their share holders about FF.

If you read the RNS and the supplementary info provided by Gixer, then the only thing you can read into it is that things are due to massively improve over the next 6 - 18 months.

The share price will only change more significantly if they make money or it becomes a safe bet that they are going to make good money in future. When they start to make money the company is a much safer investment and becomes more attractive to bigger investors. We all see how very small volume increases the price. Hopefully if bigger investor want larger volumes of shares, the price will increase quite a lot.

I've waited this long, will see where we are in another 5 years. Hopefully in a much different place.

It has the Fruitflow trademark text and contains 'Water Tomato Concentrate Powder', I think it's safe to assume it is Fruitflow.

Nesle R&D Accelerator brings together Nestlé scientists, students and start-ups to advance science and technology with the objective to accelerate the development of innovative products and systems.

So it is very good news that Nestle R&D are behind it, as they may also use FF in other products.

I am hoping that BH are building up some customers for their FF distribution throughout this year, so that come Q1 next year, they have multiple other businesses onboard, not just their own products.

So in my mind, it is submission by the end of June, then it goes for approvals, which should be "prompt" and in a "timely manner'. So perhaps by around September? A few months to get approvals and agree release of the info?

From the Sept final results RNS

By-Health currently expects to be in a position to complete the last of its eight studies and file its regulatory submission to the SAMR for Fruitflow in the first half of 2022.

Sphinx,

I am inferring that from this document, articles 19 to 24 in particular.

https://gkml-samr-gov-cn.translate.goog/nsjg/fgs/201908/t20190820_306117.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en

We know from the RNS that the scientific tests are performed by SAMR.

The SAMR submission should be complete by the end of the first half of the year, so by the end of June. The approval is expected to be prompt, whatever that means.

Amazing how it disappeared with bad reviews and came back with 5 star reviews. Magic!!

Have you got this one on your list Gix? I know the GNC Staminol is and the Blood Pressure one disappeared, but don't recall this one.

https://www.gnc.ie/gnc-scientific-nutrition-brain-health-formula-90-capsules

The product only seems to be available in the UK at the moment, which makes little sense to me for an American company (UpSpring). I can only assume it is some kind of phased rollout.

UpSpring are mainly in the US and their products are sold in CVS, Walmart, Target and Amazon, amongst a host of smaller shops. So it looks like it has potential to be our biggest reaching product yet.

I use DuckDuckGo app/browser and don’t get any adds. Internet tracking is blocked.

Would PXS need additional funding to fulfil a BH order? Probably not in my opinion. PXS have plenty of funds at the moment. Their order would be at cost to PXS. BH would probably make a number of large orders rather than Big Bang mega order. PXS could get a quick bridging loan if required. So I can’t see any need for additional funds to be raised by placing more shares.

From their site:
All our products are available in pharmacies and herbal stores throughout Poland and in our online store.

Yep. I keep reading bits about Health China 2030 and then reading the By-Health claim “ Fruitflow that can demonstrate an anti-platelet effect, inhibiting platelet function and conferring beneficial effects for people who are at risk of platelet hyperactivity-associated thrombosis - the aberrant blood clots which lead to heart attacks and strokes”

I feel that the Chinese government are linked to this by the Healthy China 2030 initiative. I have looked lots and can’t put my finger on it, just feel they are close to this.

Also if the 8 studies carried out by By-Health are published, they will draw a lot of attention. This may lead to further evidence for the likes of NHS.

China gov that is